Biorad sec filings
Web2 days ago · SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act ... WebExporting SEC Filings to Excel. XBRL is the new technology that is being used by companies to report filings to the SEC. At first it was the giant companies that complied with XBRL standards but all companies now support this which makes for pulling data easier. But let’s get down to what you really want. Exporting financial statements ...
Biorad sec filings
Did you know?
WebApr 11, 2024 · CENTRAL TRUST Co trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) by 74.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135 shares of the medical research company’s stock after … WebFeb 17, 2024 · HERCULES, Calif.—February 16, 2024 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, …
WebMar 29, 2024 · SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 02/23/2024. 8-K. Current report filing. 02/17/2024. 10-K. … Bio-Rad is a global leader in developing, manufacturing, and marketing a broad … WebApr 28, 2024 · Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 net sales were $700.1 million, a decrease of 3.7 percent compared to $726.8 million reported for the first quarter of 2024. …
WebApr 6, 2024 · Bio-Rad Laboratories, Inc. SEC Filing - Quarterly Report (10-Q) October 28, 2024 Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript Bio-Rad Labs …
WebMar 29, 2024 · SEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 02/23/2024. 8-K. Current report filing. 02/17/2024. 10-K. …
WebApr 11, 2024 · Shares of NYSE:BIO opened at $469.95 on Tuesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 4.29 and a current ratio of 5.55. Bio-Rad Laboratories, Inc. has a 52-week low of ... cpi 45u 4 post rackWebJan 9, 2024 · All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. cpi a5kWebApr 13, 2024 · Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Rating) have been assigned an average recommendation of “Buy” from the six research firms that are … cpi ana maria navales zaragozaWebSEC Filing Details. Form 4. 04/11/2024. Statement of Changes in Beneficial Ownership. PDF Format Download (opens in new window) Word Format Download (opens in new … cpi ajaWebAccess Bio-Rad's most recent SEC filings. Please note that Bio-Rad does not maintain or provide information to Q4 Inc. In addition, Bio-Rad makes no representations or … cpi ao vivohttp://bioradlab2024tf.q4web.com/sec-filings/default.aspx cpi americano hojeWebInvestor Relations Financial Reports & SEC Filings Financial Reports. QIAGEN N.V.reports its annual results under U.S. GAAP (SEC filing) due to the listing of our stock at the New York Stock Exchange. As a company established under the laws of The Netherlands we are required by law to also report under IFRS accounting standards. cpi ao vivo hang